Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 115 articles:
HTML format
Text format



Single Articles


    August 2018
  1. JAIRATH V, Peyrin-Biroulet L, Zou G, Mosli M, et al
    Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.
    Gut. 2018 Aug 3. pii: gutjnl-2018-316702. doi: 10.1136/gutjnl-2018-316702.
    PubMed     Text format     Abstract available


  2. CONCEICAO-NETO N, Deboutte W, Dierckx T, Machiels K, et al
    Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC.
    Gut. 2018;67:1558-1559.
    PubMed     Text format    


    July 2018
  3. MAO R, Chen Y, Xie X, Chen M, et al
    Gastrointestinal ultrasound in inflammatory bowel disease: experience from the Chinese IBD Elite Union.
    Gut. 2018 Jul 27. pii: gutjnl-2018-317070. doi: 10.1136/gutjnl-2018-317070.
    PubMed     Text format    


  4. WEIMERS P, Halfvarson J, Sachs MC, Ludvigsson JF, et al
    Association between inflammatory bowel disease and Parkinson's disease: seek and you shall find?
    Gut. 2018 Jul 18. pii: gutjnl-2018-316937. doi: 10.1136/gutjnl-2018-316937.
    PubMed     Text format    


  5. KIRCHGESNER J, Beaugerie L, Carrat F, Andersen NN, et al
    Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.
    Gut. 2018;67:1261-1268.
    PubMed     Text format     Abstract available


    June 2018
  6. KOTZE PG, Shen B, Lightner A, Yamamoto T, et al
    Modern management of perianal fistulas in Crohn's disease: future directions.
    Gut. 2018;67:1181-1194.
    PubMed     Text format     Abstract available


  7. BISSCHOPS R, Bessissow T, Joseph JA, Baert F, et al
    Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial.
    Gut. 2018;67:1087-1094.
    PubMed     Text format     Abstract available


  8. ZHOU G, Yu L, Fang L, Yang W, et al
    CD177(+) neutrophils as functionally activated neutrophils negatively regulate IBD.
    Gut. 2018;67:1052-1063.
    PubMed     Text format     Abstract available


    May 2018
  9. VILLUMSEN M, Aznar S, Pakkenberg B, Jess T, et al
    Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014.
    Gut. 2018 May 21. pii: gutjnl-2017-315666. doi: 10.1136/gutjnl-2017-315666.
    PubMed     Text format     Abstract available


  10. ZEISSIG S, Rosati E, Dowds CM, Aden K, et al
    Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
    Gut. 2018 May 5. pii: gutjnl-2018-316023. doi: 10.1136/gutjnl-2018-316023.
    PubMed     Text format     Abstract available


  11. TEN HOVE JR, Shah SC, Shaffer SR, Bernstein CN, et al
    Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.
    Gut. 2018 May 2. pii: gutjnl-2017-315440. doi: 10.1136/gutjnl-2017-315440.
    PubMed     Text format     Abstract available


  12. VAN STAPPEN T, Vande Casteele N, Van Assche G, Ferrante M, et al
    Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial.
    Gut. 2018;67:818-826.
    PubMed     Text format     Abstract available


    April 2018
  13. ERIKSSON C, Rundquist S, Cao Y, Montgomery S, et al
    Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study.
    Gut. 2018 Apr 4. pii: gutjnl-2017-315521. doi: 10.1136/gutjnl-2017-315521.
    PubMed     Text format     Abstract available


  14. MOUSSATA D, Allez M, Cazals-Hatem D, Treton X, et al
    Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Gut. 2018;67:616-624.
    PubMed     Text format     Abstract available


    March 2018
  15. OKUGAWA Y, Toiyama Y, Kusunoki M, Goel A, et al
    Re: Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.
    Gut. 2018 Mar 13. pii: gutjnl-2018-316205. doi: 10.1136/gutjnl-2018-316205.
    PubMed     Text format    


    February 2018
  16. BRYANT RV, Friedman A, Wright EK, Taylor K, et al
    Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application.
    Gut. 2018 Feb 3. pii: gutjnl-2017-315655. doi: 10.1136/gutjnl-2017-315655.
    PubMed     Text format     Abstract available


  17. LAHARIE D, Bourreille A, Branche J, Allez M, et al
    Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
    Gut. 2018;67:237-243.
    PubMed     Text format     Abstract available


  18. SIEGEL CA, Whitman CB, Spiegel BMR, Feagan B, et al
    Development of an index to define overall disease severity in IBD.
    Gut. 2018;67:244-254.
    PubMed     Text format     Abstract available


    January 2018
  19. ORTQVIST AK, Lundholm C, Halfvarson J, Ludvigsson JF, et al
    Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study.
    Gut. 2018 Jan 10. pii: gutjnl-2017-314352. doi: 10.1136/gutjnl-2017-314352.
    PubMed     Text format     Abstract available


  20. BOUHNIK Y, Carbonnel F, Laharie D, Stefanescu C, et al
    Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
    Gut. 2018;67:53-60.
    PubMed     Text format     Abstract available


  21. ARIJS I, De Hertogh G, Lemmens B, Van Lommel L, et al
    Effect of vedolizumab (anti-alpha4beta7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.
    Gut. 2018;67:43-52.
    PubMed     Text format     Abstract available


  22. WEISER M, Simon JM, Kochar B, Tovar A, et al
    Molecular classification of Crohn's disease reveals two clinically relevant subtypes.
    Gut. 2018;67:36-42.
    PubMed     Text format     Abstract available


  23. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Text format     Abstract available


  24. BOUHNIK Y, Mary JY
    Adalimumab in Crohn's disease and symptomatic small bowel strictures.
    Gut. 2018;67:199.
    PubMed     Text format    


  25. SONAMBEKAR AA, Desai DC, Joshi A, Dhoble P, et al
    Adalimumab in Crohn's strictures--the CREOLE study.
    Gut. 2018;67:198.
    PubMed     Text format    


    December 2017
  26. DANESE S, Fiorino G, Peyrin-Biroulet L
    Early intervention in Crohn's disease: towards disease modification trials.
    Gut. 2017;66:2179-2187.
    PubMed     Text format     Abstract available


  27. COLOMBEL JF, Keir ME, Scherl A, Zhao R, et al
    Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC.
    Gut. 2017;66:2063-2068.
    PubMed     Text format     Abstract available


    November 2017
  28. CHOI CR, Al Bakir I, Ding NJ, Lee GH, et al
    Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.
    Gut. 2017 Nov 17. pii: gutjnl-2017-314190. doi: 10.1136/gutjnl-2017-314190.
    PubMed     Text format     Abstract available


  29. PALMELA C, Chevarin C, Xu Z, Torres J, et al
    Adherent-invasive Escherichia coli in inflammatory bowel disease.
    Gut. 2017 Nov 15. pii: gutjnl-2017-314903. doi: 10.1136/gutjnl-2017-314903.
    PubMed     Text format     Abstract available


  30. KIM HS, Cheon JH, Jung ES, Park J, et al
    A coding variant in FTO confers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD.
    Gut. 2017;66:1926-1935.
    PubMed     Text format     Abstract available


  31. ZUNDLER S, Schillinger D, Fischer A, Atreya R, et al
    Blockade of alphaEbeta7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo.
    Gut. 2017;66:1936-1948.
    PubMed     Text format     Abstract available


  32. ALLEZ M, Skolnick BE, Wisniewska-Jarosinska M, Petryka R, et al
    Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial.
    Gut. 2017;66:1918-1925.
    PubMed     Text format     Abstract available


  33. HOCHART A, Gower-Rousseau C, Sarter H, Fumery M, et al
    Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.
    Gut. 2017;66:1912-1917.
    PubMed     Text format     Abstract available


  34. HOVING JC, Cutler AJ, Leeto M, Horsnell WGC, et al
    Interleukin 13-mediated colitis in the absence of IL-4Ralpha signalling.
    Gut. 2017;66:2037-2039.
    PubMed     Text format    


    October 2017
  35. NORGARD BM, Magnussen B, Larsen MD, Friedman S, et al
    Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
    Gut. 2017;66:1761-1766.
    PubMed     Text format     Abstract available


  36. JULSGAARD M, Kjeldsen J, Baumgart DC
    Vedolizumab safety in pregnancy and newborn outcomes.
    Gut. 2017;66:1866-1867.
    PubMed     Text format    


  37. SOMMER F, Ruhlemann MC, Bang C, Hoppner M, et al
    Microbiomarkers in inflammatory bowel diseases: caveats come with caviar.
    Gut. 2017;66:1734-1738.
    PubMed     Text format    


    September 2017
  38. BERTIN S, Aoki-Nonaka Y, Lee J, de Jong PR, et al
    The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1.
    Gut. 2017;66:1584-1596.
    PubMed     Text format     Abstract available


  39. GURVITS GE
    When radiology meets gastroenterology: an unusual impact.
    Gut. 2017;66:1676.
    PubMed     Text format    


    August 2017
  40. PARIAN A, Limketkai B, Koh J, Brant SR, et al
    Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis.
    Gut. 2017;66:1390-1397.
    PubMed     Text format     Abstract available


  41. NYBOE ANDERSEN N, Gortz S, Frisch M, Jess T, et al
    Reduced risk of UC in families affected by appendicitis: a Danish national cohort study.
    Gut. 2017;66:1398-1402.
    PubMed     Text format     Abstract available


  42. O'BRIEN CL, Bringer MA, Holt KE, Gordon DM, et al
    Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli.
    Gut. 2017;66:1382-1389.
    PubMed     Text format     Abstract available


    July 2017
  43. SPILLER RC, Sloan TJ
    Do diverticula provide a unique niche for microbiota which can lead to activation of the innate immune system?
    Gut. 2017;66:1175-1176.
    PubMed     Text format    


    June 2017
  44. PANES J, Sandborn WJ, Schreiber S, Sands BE, et al
    Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
    Gut. 2017;66:1049-1059.
    PubMed     Text format     Abstract available


  45. SCHWERD T, Pandey S, Yang HT, Bagola K, et al
    Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Gut. 2017;66:1060-1073.
    PubMed     Text format     Abstract available


  46. SOKOL H, Leducq V, Aschard H, Pham HP, et al
    Fungal microbiota dysbiosis in IBD.
    Gut. 2017;66:1039-1048.
    PubMed     Text format     Abstract available


    May 2017
  47. PARANG B, Kaz AM, Barrett CW, Short SP, et al
    BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.
    Gut. 2017;66:852-862.
    PubMed     Text format     Abstract available


  48. PASCAL V, Pozuelo M, Borruel N, Casellas F, et al
    A microbial signature for Crohn's disease.
    Gut. 2017;66:813-822.
    PubMed     Text format     Abstract available


  49. LEE T, Clavel T, Smirnov K, Schmidt A, et al
    Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
    Gut. 2017;66:863-871.
    PubMed     Text format     Abstract available


  50. SCHEIBE K, Backert I, Wirtz S, Hueber A, et al
    IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.
    Gut. 2017;66:823-838.
    PubMed     Text format     Abstract available


    April 2017
  51. LORD AR, Simms LA, Hanigan K, Sullivan R, et al
    Protective effects of Helicobacter pylori for IBD are related to the cagA-positive strain.
    Gut. 2017 Apr 13. pii: gutjnl-2017-313805. doi: 10.1136/gutjnl-2017-313805.
    PubMed     Text format    


  52. LIN W, Ma C, Su F, Jiang Y, et al
    Raf kinase inhibitor protein mediates intestinal epithelial cell apoptosis and promotes IBDs in humans and mice.
    Gut. 2017;66:597-610.
    PubMed     Text format     Abstract available


    March 2017
  53. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The reduced chance of a live birth in women with IBD receiving assisted reproduction is due to a failure to achieve a clinical pregnancy.
    Gut. 2017;66:556-558.
    PubMed     Text format    


    February 2017
  54. NOBEN M, Verstockt B, de Bruyn M, Hendriks N, et al
    Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?
    Gut. 2017 Feb 3. pii: gutjnl-2016-313667. doi: 10.1136/gutjnl-2016-313667.
    PubMed     Text format    


  55. SUBRAMANIAN S, Ekbom A, Rhodes JM
    Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?
    Gut. 2017;66:362-381.
    PubMed     Text format     Abstract available


  56. CASTANO-RODRIGUEZ N, Kaakoush NO, Lee WS, Mitchell HM, et al
    Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.
    Gut. 2017;66:235-249.
    PubMed     Text format     Abstract available


  57. QURAISHI MN, Sergeant M, Kay G, Iqbal T, et al
    The gut-adherent microbiota of PSC-IBD is distinct to that of IBD.
    Gut. 2017;66:386-388.
    PubMed     Text format    


    January 2017
  58. MOSLI MH, Feagan BG, Zou G, Sandborn WJ, et al
    Development and validation of a histological index for UC.
    Gut. 2017;66:50-58.
    PubMed     Text format     Abstract available


  59. MARCHAL-BRESSENOT A, Salleron J, Boulagnon-Rombi C, Bastien C, et al
    Development and validation of the Nancy histological index for UC.
    Gut. 2017;66:43-49.
    PubMed     Text format     Abstract available


  60. MACHIELS K, Sabino J, Vandermosten L, Joossens M, et al
    Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.
    Gut. 2017;66:79-88.
    PubMed     Text format     Abstract available


  61. ATREYA I, Neurath MF
    Microbiota: relevant player in thiopurine metabolisation?
    Gut. 2017;66:1-3.
    PubMed     Text format    


  62. DONG R, Zheng S, Chen G
    The appropriate dose and cost of iron replacement therapy in patients with IBD.
    Gut. 2017;66:196-197.
    PubMed     Text format    


  63. GUINET-CHARPENTIER C, Lepage P, Morali A, Chamaillard M, et al
    Effects of enteral polymeric diet on gut microbiota in children with Crohn's disease.
    Gut. 2017;66:194-195.
    PubMed     Text format    


    November 2016
  64. OLIVERA P, Danese S, Peyrin-Biroulet L
    Next generation of small molecules in inflammatory bowel disease.
    Gut. 2016 Nov 17. pii: gutjnl-2016-312912. doi: 10.1136/gutjnl-2016-312912.
    PubMed     Text format    


  65. TEICH N, Bokemeyer B, Mohl W, Walldorf J, et al
    Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.
    Gut. 2016 Nov 14. pii: gutjnl-2016-313138. doi: 10.1136/gutjnl-2016-313138.
    PubMed     Text format    


  66. DOTTI I, Mora-Buch R, Ferrer-Picon E, Planell N, et al
    Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis.
    Gut. 2016 Nov 1. pii: gutjnl-2016-312609. doi: 10.1136/gutjnl-2016-312609.
    PubMed     Text format     Abstract available


    October 2016
  67. IMHANN F, Vich Vila A, Bonder MJ, Fu J, et al
    Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Gut. 2016 Oct 8. pii: gutjnl-2016-312135. doi: 10.1136/gutjnl-2016-312135.
    PubMed     Text format     Abstract available


    September 2016
  68. HASLER R, Sheibani-Tezerji R, Sinha A, Barann M, et al
    Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease.
    Gut. 2016 Sep 30. pii: gutjnl-2016-311651. doi: 10.1136/gutjnl-2016-311651.
    PubMed     Text format     Abstract available


    July 2016
  69. JENDREK ST, Gotthardt D, Nitzsche T, Widmann L, et al
    Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
    Gut. 2016 Jul 12. pii: gutjnl-2016-311739. doi: 10.1136/gutjnl-2016-311739.
    PubMed     Text format     Abstract available


    May 2016
  70. STARR AE, Deeke SA, Ning Z, Chiang CK, et al
    Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC.
    Gut. 2016 May 23. pii: gutjnl-2015-310705. doi: 10.1136/gutjnl-2015-310705.
    PubMed     Text format     Abstract available


  71. SABINO J, Vieira-Silva S, Machiels K, Joossens M, et al
    Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Gut. 2016 May 20. pii: gutjnl-2015-311004. doi: 10.1136/gutjnl-2015-311004.
    PubMed     Text format     Abstract available


  72. QUEVRAIN E, Maubert MA, Sokol H, Devreese B, et al
    The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem.
    Gut. 2016;65:882.
    PubMed     Text format    


  73. HONG SN, Park C, Park SJ, Lee CK, et al
    Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants.
    Gut. 2016;65:788-96.
    PubMed     Text format     Abstract available


    April 2016
  74. CANAVAN JB, Scotta C, Vossenkamper A, Goldberg R, et al
    Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Gut. 2016;65:584-94.
    PubMed     Text format     Abstract available


    March 2016
  75. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed     Text format    


  76. TURSI A, Principi M, Picchio M, Giorgio F, et al
    Persistence of endoscopic rectal inflammation in UC treated with infliximab is not linked to ineffective TNFalpha downregulation.
    Gut. 2016;65:539-40.
    PubMed     Text format    


  77. HORNEF MW, Pabst O
    Real friends: Faecalibacterium prausnitzii supports mucosal immune homeostasis.
    Gut. 2016;65:365-7.
    PubMed     Text format    


  78. QUEVRAIN E, Maubert MA, Michon C, Chain F, et al
    Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
    Gut. 2016;65:415-25.
    PubMed     Text format     Abstract available


  79. BRYANT RV, Burger DC, Delo J, Walsh AJ, et al
    Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Gut. 2016;65:408-14.
    PubMed     Text format     Abstract available


    February 2016
  80. NORGARD BM, Larsen PV, Fedder J, de Silva PS, et al
    Live birth and adverse birth outcomes in women with ulcerative colitis and Crohn's disease receiving assisted reproduction: a 20-year nationwide cohort study.
    Gut. 2016 Feb 26. pii: gutjnl-2015-311246. doi: 10.1136/gutjnl-2015-311246.
    PubMed     Text format     Abstract available


  81. COLOMBEL JF, Sands BE, Rutgeerts P, Sandborn W, et al
    The safety of vedolizumab for ulcerative colitis and Crohn's disease.
    Gut. 2016 Feb 18. pii: gutjnl-2015-311079. doi: 10.1136/gutjnl-2015-311079.
    PubMed     Text format     Abstract available


  82. KUMMEN M, Holm K, Anmarkrud JA, Nygard S, et al
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Gut. 2016 Feb 17. pii: gutjnl-2015-310500. doi: 10.1136/gutjnl-2015-310500.
    PubMed     Text format     Abstract available


  83. MARCHESI JR, Adams DH, Fava F, Hermes GD, et al
    The gut microbiota and host health: a new clinical frontier.
    Gut. 2016;65:330-9.
    PubMed     Text format     Abstract available


  84. CHAMAILLARD M, Radulovic K
    Defining dysbiosis threatens Koch's postulates and current dogma on the role of Paneth cells in Crohn's disease.
    Gut. 2016;65:190-1.
    PubMed     Text format    


  85. SCHAUBECK M, Clavel T, Calasan J, Lagkouvardos I, et al
    Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.
    Gut. 2016;65:225-37.
    PubMed     Text format     Abstract available


  86. REHMAN A, Rausch P, Wang J, Skieceviciene J, et al
    Geographical patterns of the standing and active human gut microbiome in health and IBD.
    Gut. 2016;65:238-48.
    PubMed     Text format     Abstract available


    December 2015
  87. GOWER-ROUSSEAU C, Sarter H, Savoye G, Tavernier N, et al
    Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort.
    Gut. 2015 Dec 8. pii: gutjnl-2015-310151. doi: 10.1136/gutjnl-2015-310151.
    PubMed     Text format     Abstract available


  88. TURNER D, Doveh E, Cohen A, Wilson ML, et al
    Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Gut. 2015;64:1898-904.
    PubMed     Text format     Abstract available


  89. ZEISSIG S, Petersen BS, Tomczak M, Melum E, et al
    Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.
    Gut. 2015;64:1889-97.
    PubMed     Text format     Abstract available


    November 2015
  90. MOSLI MH, Feagan BG, Zou G, Sandborn WJ, et al
    Reproducibility of histological assessments of disease activity in UC.
    Gut. 2015;64:1765-73.
    PubMed     Text format     Abstract available


  91. WU W, He C, Liu C, Cao AT, et al
    miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
    Gut. 2015;64:1755-64.
    PubMed     Text format     Abstract available


    October 2015
  92. VANDE CASTEELE N, Khanna R, Levesque BG, Stitt L, et al
    The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.
    Gut. 2015;64:1539-45.
    PubMed     Text format     Abstract available


  93. SADAGHIAN SADABAD M, Regeling A, de Goffau MC, Blokzijl T, et al
    The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients.
    Gut. 2015;64:1546-52.
    PubMed     Text format     Abstract available


    September 2015
  94. DANESE S, Peyrin-Biroulet L, Fiorino G
    Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?
    Gut. 2015;64:1347-8.
    PubMed     Text format    


  95. BOETTLER T, Lutz L, Schmidt N, Thimme R, et al
    An uncommon presentation of a common pathogen.
    Gut. 2015;64:1411.
    PubMed     Text format    


  96. JAUREGUI-AMEZAGA A, Rimola J, Ordas I, Rodriguez S, et al
    Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics.
    Gut. 2015;64:1397-402.
    PubMed     Text format     Abstract available


  97. BRESSENOT A, Salleron J, Bastien C, Danese S, et al
    Comparing histological activity indexes in UC.
    Gut. 2015;64:1412-8.
    PubMed     Text format     Abstract available


  98. BERNSTEIN CN, Nugent Z, Targownik LE, Singh H, et al
    Predictors and risks for death in a population-based study of persons with IBD in Manitoba.
    Gut. 2015;64:1403-11.
    PubMed     Text format     Abstract available


    August 2015
  99. BOSCHETTI G, Assaad S, Balme B, Boyer S, et al
    A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease.
    Gut. 2015 Aug 5. pii: gutjnl-2015-310130. doi: 10.1136/gutjnl-2015-310130.
    PubMed     Text format    


  100. BILLIET T, Vande Casteele N, Van Stappen T, Princen F, et al
    Immunogenicity to infliximab is associated with HLA-DRB1.
    Gut. 2015;64:1344-5.
    PubMed     Text format    


  101. STEENHOLDT C, Ainsworth MA
    Authors' response: Importance of defining loss of response before therapeutic drug monitoring.
    Gut. 2015;64:1340-1.
    PubMed     Text format    


  102. D'HAENS G, Sandborn WJ, Colombel JF, Rutgeerts P, et al
    A phase II study of laquinimod in Crohn's disease.
    Gut. 2015;64:1227-35.
    PubMed     Text format     Abstract available


    July 2015
  103. CIUCCI T, Ibanez L, Boucoiran A, Birgy-Barelli E, et al
    Bone marrow Th17 TNFalpha cells induce osteoclast differentiation, and link bone destruction to IBD.
    Gut. 2015;64:1072-81.
    PubMed     Text format     Abstract available


  104. SYRBE U, Siegmund B
    Bone marrow Th17 TNFalpha cells induce osteoclast differentiation and link bone destruction to IBD.
    Gut. 2015;64:1011-2.
    PubMed     Text format    


  105. LAKATOS PL, Burisch J
    Environment and invironment in IBDs: partners in crime.
    Gut. 2015;64:1009-10.
    PubMed     Text format    


    June 2015
  106. HART PA, Levy MJ, Smyrk TC, Takahashi N, et al
    Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience.
    Gut. 2015 Jun 17. pii: gutjnl-2015-309275. doi: 10.1136/gutjnl-2015-309275.
    PubMed     Text format     Abstract available


  107. REINISCH W, Panes J, Khurana S, Toth G, et al
    Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.
    Gut. 2015;64:894-900.
    PubMed     Text format     Abstract available


  108. BOUGUEN G, Langlois A, Djouina M, Branche J, et al
    Intestinal steroidogenesis controls PPARgamma expression in the colon and is impaired during ulcerative colitis.
    Gut. 2015;64:901-10.
    PubMed     Text format     Abstract available


    May 2015
  109. KHALILI H, Chan AT
    Author response: oral contraceptives and Crohn's disease.
    Gut. 2015;64:854.
    PubMed     Text format    


  110. FU SH, Lin MH, Yeh LT, Wang YL, et al
    Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.
    Gut. 2015;64:765-75.
    PubMed     Text format     Abstract available


  111. NALLEWEG N, Chiriac MT, Podstawa E, Lehmann C, et al
    IL-9 and its receptor are predominantly involved in the pathogenesis of UC.
    Gut. 2015;64:743-55.
    PubMed     Text format     Abstract available


    April 2015
  112. YANG SK, Ye BD, Song K
    ATG16L1 contributes to Crohn's disease susceptibility in Koreans: overmuch concern for ethnic difference?
    Gut. 2015;64:687-8.
    PubMed     Text format    


  113. JAMES SL, Christophersen CT, Bird AR, Conlon MA, et al
    Abnormal fibre usage in UC in remission.
    Gut. 2015;64:562-70.
    PubMed     Text format     Abstract available


  114. GENUA M, D'Alessio S, Cibella J, Gandelli A, et al
    The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation.
    Gut. 2015;64:589-600.
    PubMed     Text format     Abstract available


    December 2014
  115. JOOSSE ME, Schipper ME, Libbrecht L, Buuren HR, et al
    Recurrent cholangitis in a 65-year-old man.
    Gut. 2014 Dec 22. pii: gutjnl-2014-308726. doi: 10.1136/gutjnl-2014-308726.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: